Published in Acta Orthop on September 19, 2014
Accuracy of diagnostic tests for prosthetic joint infection: a systematic review. Knee Surg Sports Traumatol Arthrosc (2016) 0.89
Development of an in vitro Assay, Based on the BioFilm Ring Test(®), for Rapid Profiling of Biofilm-Growing Bacteria. Front Microbiol (2016) 0.78
Revision of infected knee arthroplasties in Denmark. Acta Orthop (2016) 0.77
Beyond conventional antibiotics - New directions for combination products to combat biofilm. Adv Drug Deliv Rev (2016) 0.77
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections. Infect Drug Resist (2016) 0.75
Reduced ability to detect surface-related biofilm bacteria after antibiotic exposure under in vitro conditions. Acta Orthop (2016) 0.75
Antibacterial potency of different deposition methods of silver and copper containing diamond-like carbon coated polyethylene. Biomater Res (2016) 0.75
Orthopedic Prosthetic Infections: Diagnosis and Orthopedic Salvage. Semin Plast Surg (2016) 0.75
Low sensitivity of implant sonication when screening for infection in revision surgery. Acta Orthop (2017) 0.75
Inhibition of biofilm formation on iodine-supported titanium implants. Int Orthop (2017) 0.75
EKA survey: diagnosis of prosthetic knee joint infection. Knee Surg Sports Traumatol Arthrosc (2016) 0.75
Understanding biomaterial-tissue interface quality: combined in vitro evaluation. Sci Technol Adv Mater (2017) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
Microbial biofilms. Annu Rev Microbiol (1995) 21.58
Prosthetic-joint infections. N Engl J Med (2004) 12.71
Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol (2001) 11.67
Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2012) 8.56
Extracellular DNA required for bacterial biofilm formation. Science (2002) 8.25
Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med (2007) 7.82
Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother (1985) 7.31
The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun (1999) 7.22
Riddle of biofilm resistance. Antimicrob Agents Chemother (2001) 7.19
Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol (1996) 7.16
MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol (1994) 7.14
Biofilm, city of microbes. J Bacteriol (2000) 5.79
Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol (1997) 5.47
Biomaterial-centered infection: microbial adhesion versus tissue integration. Science (1987) 5.38
The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am (2009) 5.33
Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect (2007) 4.55
Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA (2006) 4.53
A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol (2006) 4.49
Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis (2000) 4.19
Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res (2001) 4.15
The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci U S A (2007) 4.07
Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 3.78
[Depot effects of various antibiotics mixed with Palacos resins]. Chirurg (1970) 3.74
What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open (2012) 3.56
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet (1991) 3.26
A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem (2004) 3.05
Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA (1995) 2.94
Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun (1999) 2.92
Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology (2007) 2.92
Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol (2007) 2.90
Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis (2003) 2.82
Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J (2013) 2.72
Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol (2009) 2.69
A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun (1997) 2.65
Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis (2006) 2.53
A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51
A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis (2012) 2.46
Infection after total hip arthroplasty. The Avon experience. J Bone Joint Surg Br (2003) 2.44
How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci U S A (2012) 2.43
Animal antimicrobial peptides: an overview. Biopolymers (1998) 2.42
Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis (1994) 2.37
Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br (1998) 2.30
Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect Immun (1999) 2.29
Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol (2005) 2.29
Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am (1985) 2.27
Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother (1993) 2.24
Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases. J Bone Joint Surg Am (2009) 2.21
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother (2007) 2.10
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros (2004) 2.08
A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res (2005) 1.97
Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol (2010) 1.94
Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol (2010) 1.92
Management of deep infection of total hip replacement. J Bone Joint Surg Br (1981) 1.90
Hematogenous infection in total joint replacement. Clin Orthop Relat Res (1979) 1.89
Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr (2007) 1.89
Prevention and control of bacterial infections associated with medical devices. ASAIO J (1993) 1.88
Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J Bacteriol (2008) 1.88
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol (2008) 1.88
The clinical impact of bacterial biofilms. Int J Oral Sci (2011) 1.88
Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J Infect Dis (2004) 1.86
Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res (2003) 1.82
Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol (2008) 1.81
In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg Am (2007) 1.79
Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2004) 1.79
Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials (2012) 1.79
Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2002) 1.76
One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother (2009) 1.74
Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol (2011) 1.73
Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J Infect Dis (1996) 1.72
Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros (2005) 1.71
A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc Natl Acad Sci U S A (2008) 1.70
Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother (2009) 1.67
Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol (2009) 1.67
Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials (2007) 1.66
Biofilms and chronic infections. JAMA (2008) 1.65
Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop (2009) 1.64
Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol (2010) 1.62
Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J Clin Microbiol (2012) 1.62
Pros and cons of phage therapy. Bacteriophage (2011) 1.56
Detection of biomaterial-associated infections in orthopaedic joint implants. Clin Orthop Relat Res (2003) 1.54
Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother (2010) 1.54
The future of biologic coatings for orthopaedic implants. Biomaterials (2013) 1.53
Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am (2013) 1.51
Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report. J Bone Joint Surg Am (2008) 1.46
Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am (2009) 1.45
Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol (2012) 1.43
A review of the scientific evidence for biofilms in wounds. Wound Repair Regen (2012) 1.42
Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J Clin Microbiol (2007) 1.42
Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res (1988) 1.41
Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J Bacteriol (2010) 1.40
Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs (2006) 1.37
The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin. Mol Microbiol (2009) 1.36
Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep (2008) 1.34
Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure. J Infect (2012) 1.33
Confocal laser scanning microscopy for analysis of microbial biofilms. Methods Enzymol (1999) 1.28
The discovery of microorganisms by Robert Hooke and Antoni Van Leeuwenhoek, fellows of the Royal Society. Notes Rec R Soc Lond (2004) 1.25
Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun (2011) 1.24
Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother (2009) 1.23
Bacteria isolated from deep joint sepsis after operation for total hip or knee replacement and the sources of the infections with Staphylococcus aureus. J Hosp Infect (1983) 1.23
A comparison of the validity and reliability of established bone stock loss classification systems and the proposal of a novel classification system. Hip Int (2010) 0.96
The TARGET cohort study protocol: a prospective primary care cohort study to derive and validate a clinical prediction rule to improve the targeting of antibiotics in children with respiratory tract illnesses. BMC Health Serv Res (2013) 0.94
Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea. Invest Ophthalmol Vis Sci (2009) 0.84
Evidence of excessive concentrations of 5-flucytosine in children aged below 12 years: a 12-year review of serum concentrations from a UK clinical assay reference laboratory. Int J Antimicrob Agents (2006) 0.83
The effect of a modified posterior approach on blood flow to the femoral head during hip resurfacing. Hip Int (2009) 0.81
A reverse-phase HPLC assay for the simultaneous determination of enrofloxacin and ciprofloxacin in pig faeces. Int J Antimicrob Agents (2004) 0.80
Assay of ertapenem in human serum by high-performance liquid chromatography. Int J Antimicrob Agents (2006) 0.80
Gentamicin concentrations in diagnostic aspirates from 25 patients with hip and knee arthroplasties. Acta Orthop Scand (2004) 0.76
Antibiotic elution from bone cement: A study of common cement-antibiotic combinations. Hip Int (2017) 0.75
Determination of avilamycin A and B in pig faeces by solid phase extraction and reverse-phase HPLC assay. Int J Antimicrob Agents (2004) 0.75
Determination by HPLC of chlortetracycline in pig faeces. J Antimicrob Chemother (2003) 0.75
Stem compatibility for cement-in-cement femoral revision: an in vitro study. Hip Int (2014) 0.75